Vanguard Capital Management
PAHC icon

Vanguard Capital Management’s Phibro Animal Health PAHC Stock Holding History

Vanguard Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29M Buy
923,318
+32,035
+4% +$1.35M ﹤0.01% 2240
2026
Q1 		$49.3M Buy
+891,283
New +$42.4M ﹤0.01% 1856

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CM
CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return

Vanguard Capital Management's PAHC Position: Q2 2026 in Review

Vanguard Capital Management increased its Phibro Animal Health (PAHC) stake by 3.6% in Q2 2026, buying an estimated $1.35M and bringing the position to 923,318 shares worth $29M. The position accounts for ﹤0.01% of the portfolio, ranked #2240.

Vanguard Capital Management first reported a position in PAHC in Q1 2026 and has held it in 2 quarters since. The position peaked at $49.3M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Vanguard Capital Management held 923,318 shares of Phibro Animal Health worth $29M as of Q2 2026.
  • Vanguard Capital Management bought 32,035 Phibro Animal Health shares in Q2 2026, an estimated $1.35M.
  • Phibro Animal Health made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2240 holding.
  • Vanguard Capital Management first reported a position in Phibro Animal Health in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Phibro Animal Health position peaked at $49.3M in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.